Items where authors include "Love, S"
Up a levelArticle
Phillips, R, Cro, S, Wheeler, G et al. (22 more authors) (2022) Visualising harms in publications of randomised controlled trials: consensus and recommendations. BMJ, 377. e068983. ISSN 1759-2151
Lauwers, E, Lalli, G, Brandner, S et al. (34 more authors) (2020) Potential human transmission of amyloid β pathology: surveillance and risks. Lancet Neurology, 19 (10). pp. 872-878. ISSN 1474-4422
Thomas, A, Virdee, PS, Eatock, M et al. (10 more authors) (2020) Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma. European Journal of Cancer, 124. pp. 131-141. ISSN 0959-8049
Horsburgh, K, Wardlaw, JM, van Agtmael, T et al. (43 more authors) (2018) Small vessels, dementia and chronic diseases – molecular mechanisms and pathophysiology. Clinical Science, 132 (8). pp. 851-868. ISSN 0143-5221
Buas, MF, He, Q, Johnson, LG et al. (37 more authors) (2017) Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Gut, 66 (10). pp. 1739-1737. ISSN 0017-5749
Palles, C, Chegwidden, L, Li, X et al. (95 more authors) (2015) Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett's Esophagus. Gastroenterology, 148 (2). pp. 367-378. ISSN 0016-5085
Palles, C, Chegwidden, L, Li, X et al. (95 more authors) (2015) Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus. Gastroenterology, 148 (2). pp. 367-378. ISSN 0016-5085
Masurekar, A, Fong, C, Hussain, A et al. (7 more authors) (2014) The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial. Blood Cancer Journal, 4. e203. ISSN 2044-5385
Rosmarin, D, Palles, C, Church, D et al. (41 more authors) (2014) Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. Journal of Clinical Oncology, 32 (10). 1031 - 1039. ISSN 0732-183X